GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » CM Life Sciences II Inc (NAS:CMIIU) » Definitions » Change In Payables And Accrued Expense

CM Life Sciences II (CM Life Sciences II) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Dec. 2020)


View and export this data going back to 2021. Start your Free Trial

What is CM Life Sciences II Change In Payables And Accrued Expense?

CM Life Sciences II's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2020 was $0.00 Mil. It means CM Life Sciences II's Accounts Payable & Accrued Expense stayed the same from . 20 to Dec. 2020 .

CM Life Sciences II's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2020 was $0.00 Mil. It means CM Life Sciences II's Accounts Payable & Accrued Expense stayed the same from . 20 to Dec. 2020 .


CM Life Sciences II Change In Payables And Accrued Expense Historical Data

The historical data trend for CM Life Sciences II's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CM Life Sciences II Change In Payables And Accrued Expense Chart

CM Life Sciences II Annual Data
Trend Dec20
Change In Payables And Accrued Expense
-

CM Life Sciences II Semi-Annual Data
Dec20
Change In Payables And Accrued Expense -

CM Life Sciences II Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CM Life Sciences II Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of CM Life Sciences II's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CM Life Sciences II (CM Life Sciences II) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
c/o Corvex Management LP, 667 Madison Avenue, New York, NY, USA, 10065
CM Life Sciences II Inc is a blank check company.